These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23601760)

  • 1. A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy.
    Park HS; Kim HY; Park S; Kim EK; Kim SI; Park BW
    Breast; 2013 Oct; 22(5):869-73. PubMed ID: 23601760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.
    Lee SK; Yang JH; Woo SY; Lee JE; Nam SJ
    Br J Surg; 2013 Dec; 100(13):1756-63. PubMed ID: 24227361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
    Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
    J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
    Jakub JW; Murphy BL; Gonzalez AB; Conners AL; Henrichsen TL; Maimone S; Keeney MG; McLaughlin SA; Pockaj BA; Chen B; Musonza T; Harmsen WS; Boughey JC; Hieken TJ; Habermann EB; Shah HN; Degnim AC
    Ann Surg Oncol; 2017 Oct; 24(10):2915-2924. PubMed ID: 28766196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy-Original Study and Critical Evaluation of the Literature.
    Dória MT; Maesaka JY; Soares de Azevedo Neto R; de Barros N; Baracat EC; Filassi JR
    Clin Breast Cancer; 2018 Oct; 18(5):e805-e812. PubMed ID: 29798815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy.
    Shigematsu H; Kadoya T; Masumoto N; Matsuura K; Emi A; Kajitani K; Amioka A; Okada M
    Clin Breast Cancer; 2014 Oct; 14(5):358-64. PubMed ID: 24962555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
    Schulz S; Sinn P; Golatta M; Rauch G; Junkermann H; Schuetz F; Sohn C; Heil J
    Breast; 2013 Aug; 22(4):537-42. PubMed ID: 23237921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast.
    Kim S; Kim J; Park HS; Kim HY; Lee K; Lee J; Lee H; Kim JY; Kim SI; Cho YU; Park BW
    Yonsei Med J; 2019 Nov; 60(11):1028-1035. PubMed ID: 31637884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
    Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
    Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
    Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
    Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
    Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
    World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
    Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
    Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
    Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
    Hung WK; Ying M; Chan M; Mak KL; Chan LK
    Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
    Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
    Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of invasive breast cancer in ductal carcinoma in situ initially diagnosed by core biopsy.
    Chan MY; Lim S
    Asian J Surg; 2010 Apr; 33(2):76-82. PubMed ID: 21029943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
    Wilkie C; White L; Dupont E; Cantor A; Cox CE
    Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
    Brennan ME; Turner RM; Ciatto S; Marinovich ML; French JR; Macaskill P; Houssami N
    Radiology; 2011 Jul; 260(1):119-28. PubMed ID: 21493791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.